CMS rolls back durable medical equipment reporting rules … High rates of lasting dementia, psychosis found in large COVID study … Kentucky providers affected by severe storms, severe flooding get reporting...
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...